Please login to the form below

Not currently logged in
Email:
Password:

McCann Health expands consulting team

Two new managing directors appointed

Business consultancy McCann Health has appointed two new managing directors - Robert Paglia and Randy Goodman - to the firm as a result of expanding projects.

Prior to McCann Health, Robert Paglia has held a number of senior roles such as US head, pricing and market access for PriceSpective, founder and president of Evolution Health Initiatives and various sales and marketing positions at Johnson & Johnson, Purdue Pharma and Bristol-Myers Squibb.

In addition to Paglia, Randy Goodman joins McCann Health bringing more than 23 years of experience from both the public and private sector.

Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.

Goodman also worked for the White House office on reform and health policy during both the Clinton and Obama administrations.

Simon Holt, president of consulting at McCann Health, said: “We’re delighted to welcome two new senior executives to the NY management team with expertise in developing new approaches to meet the needs of today’s customers, more effective market access and pricing solutions, and fresh approaches to embedding the latest marketing and business strategies into entire organisations.”

11th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics